Home » Stocks » AMRS

Amyris, Inc. (AMRS)

Stock Price: $15.11 USD 0.04 (0.27%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $15.18 +0.07 (0.46%) Jul 29, 7:55 PM
Market Cap 4.47B
Revenue (ttm) 320.87M
Net Income (ttm) -585.80M
Shares Out 267.73M
EPS (ttm) -2.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $15.11
Previous Close $15.07
Change ($) 0.04
Change (%) 0.27%
Day's Open 15.00
Day's Range 14.82 - 15.54
Day's Volume 1,661,317
52-Week Range 1.88 - 23.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

The indices are on pace to end the week in the green, backed by a 4-day winning streak. Make the most of this market with today's best short plays from Q.ai's deep learning algorithms.

Other stocks mentioned: FLR, LTHM, LVS, RDFN
6 days ago - Forbes

EMERYVILLE, Calif., July 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer bran...

1 week ago - PRNewsWire

EMERYVILLE, Calif., July 21, 2021 /PRNewswire/ --  Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer br...

1 week ago - PRNewsWire

Shares of AMRS stock are on the move today as retail investors appear to be intrigued by this name, providing buying momentum. The post AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today appe...

1 week ago - InvestorPlace

Markets started off the week right where they left off on Friday, with a sharp pullback at the open. Find opportunities with today's best short plays from Q.ai's artificial intelligence.

Other stocks mentioned: FLR, BLNK, CVNA, PLUG
1 week ago - Forbes

The Dow, the S&P 500, and the Nasdaq are all in the red after a morning surge. Find opportunities in this market with today's best short plays from Q.ai's deep learning algorithms.

Other stocks mentioned: CVNA, LTHM, NCMI, RDFN
1 week ago - Forbes

Thursday marked a lower day on Wall Street with all three indices trading in the red, albeit slightly. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

2 weeks ago - Forbes

The S&P 500 is up more than 16% now this year and over 36% in the last 12 months. Make the most of this market with today's best short plays from Q.ai's artificial intelligence.

Other stocks mentioned: CVNA, BLNK, FLR, PLUG
2 weeks ago - Forbes

EMERYVILLE, Calif., July 13, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer bran...

2 weeks ago - PRNewsWire

Shares of these overlooked gems could make investors very rich once the rest of the market notices their value.

Other stocks mentioned: OCUL, RNLX
2 weeks ago - The Motley Fool

Markets were well in the red this morning with the S&P off about 1.2%, the Dow lower by about 1%, and the Nasdaq taking the brunt of selling pressure down just under 1.5%. Find opportunities in today's ...

Other stocks mentioned: CVNA, BLNK, FLR, LTHM
3 weeks ago - Forbes

The S&P 500 moved higher this morning, led by tech stocks, as the Nasdaq aimed for another record open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

Other stocks mentioned: FLR, BLNK, CVNA, PLUG
3 weeks ago - Forbes

EMERYVILLE, Calif., July 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a t...

4 weeks ago - PRNewsWire

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...

Other stocks mentioned: ARNA, CGC, CRON, HEXO, IIPR, JVA
1 month ago - Schaeffers Research

EMERYVILLE, Calif., June 17, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today ...

1 month ago - PRNewsWire

EMERYVILLE, Calif., June 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today ...

1 month ago - PRNewsWire

EMERYVILLE, Calif., June 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...

1 month ago - PRNewsWire

EMERYVILLE, Calif., June 2, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today a...

1 month ago - PRNewsWire

Jobless claims fell to yet another pandemic-era low, and cyclical stocks popped while the rotation out of tech continued for another day. Meanwhile, Q.ai's Artificial Intelligence systems have assessed ...

Other stocks mentioned: BLNK
2 months ago - Forbes

One of these things is (no longer) like the others.

Other stocks mentioned: AMTX, GEVO
2 months ago - The Motley Fool

The Dow Jones rose 70 points, the S&P 500 gained 0.3%, and the Nasdaq climbed 0.6%. Meanwhile, Q.ai's artificial intelligence has assessed each firm to find the best short plays of the day.

2 months ago - Forbes

Although stocks were deeply in the red in overnight trading, the jobless claims can be credited for the sharp reversal today. Q.ai's artificial intelligence systems assessed each firm to find the best s...

Other stocks mentioned: CVNA
2 months ago - Forbes

The major indices have all traded in the red. But, if you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts.

Other stocks mentioned: KEX, BLNK, LTHM, PLUG
2 months ago - Forbes

EMERYVILLE, Calif., May 18, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a to...

2 months ago - PRNewsWire

Going into today, the Dow Jones continued its sell-off and fell more than 150 points while the S&P 500 lost 0.6% and the Nasdaq dipped more than 1%. Our AI has identified the following stocks rated To...

Other stocks mentioned: CVNA, RDFN, BLNK, RETA
2 months ago - Forbes

EMERYVILLE, Calif., May 11, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today a...

2 months ago - PRNewsWire

The major indices are trading mixed amid signs that reopening and recovery are on the horizon. If you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the dat...

Other stocks mentioned: CEVA, FLR, MAXR, RDFN
2 months ago - Forbes

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -575.00% and 367.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

EMERYVILLE, Calif., May 6, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today an...

2 months ago - PRNewsWire

EMERYVILLE, Calif., May 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier o...

2 months ago - PRNewsWire

Amyris' (AMRS) Q1 results are likely to have benefited from continued strong growth in its consumer brands.

2 months ago - Zacks Investment Research

EMERYVILLE, Calif. and WESTCHESTER, Ill.

Other stocks mentioned: INGR
2 months ago - PRNewsWire

Amyris, Inc. (AMRS) closed at $14.56 in the latest trading session, marking a -1.42% move from the prior day.

2 months ago - Zacks Investment Research

Amyris, Inc. (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

EMERYVILLE, Calif., April 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...

3 months ago - PRNewsWire

EMERYVILLE, Calif., April 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...

3 months ago - PRNewsWire

EMERYVILLE, Calif., April 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

3 months ago - PRNewsWire

EMERYVILLE, Calif., April 14, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

3 months ago - PRNewsWire

Amyris, Inc. (NASDAQ:AMRS) is a synthetic biotech and renewable chemical company.

3 months ago - Schaeffers Research

EMERYVILLE, Calif., April 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...

3 months ago - PRNewsWire

EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...

3 months ago - PRNewsWire

If you check the summary page for Amyris Inc. (NASDAQ:AMRS) at GuruFocus, you'll find a lot of weak metrics. That includes ratings of 1 out of 10 for both financial strength and profitability.

3 months ago - GuruFocus

A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On ap...

Other stocks mentioned: DCP, EXPI, FLGT, FUTU, MIK, SI, SPWR
3 months ago - InvestorPlace

EMERYVILLE, Calif., April 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...

3 months ago - PRNewsWire

EMERYVILLE, Calif., April 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...

3 months ago - PRNewsWire

EMERYVILLE, Calif., March 31, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

3 months ago - PRNewsWire

EMERYVILLE, Calif., March 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

4 months ago - PRNewsWire

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Amazon and Microsoft

Other stocks mentioned: ADUS, AMZN, ATEC, MSFT
4 months ago - CNBC

EMERYVILLE, Calif., March 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

4 months ago - PRNewsWire

The market for sustainable personal care products is booming. Amyris, one of the earliest synthetic biology companies, is launching new brands to ride the wave.

4 months ago - Forbes

About AMRS

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Ins... [Read more...]

Industry
Specialty Chemicals
IPO Date
Sep 28, 2010
CEO
John Melo
Employees
595
Stock Exchange
NASDAQ
Ticker Symbol
AMRS
Full Company Profile

Financial Performance

In 2020, Amyris's revenue was $173.14 million, an increase of 13.49% compared to the previous year's $152.56 million. Losses were -$331.04 million, 36.4% more than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Amyris stock is "Strong Buy." The 12-month stock price forecast is 24.00, which is an increase of 58.84% from the latest price.

Price Target
$24.00
(58.84% upside)
Analyst Consensus: Strong Buy